| NMR Experiment |
|---|
| Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
|---|
| 1 | 2D 1H-1H TOCSY | 0.23 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: beta3-Leu13, beta3-Asn17, beta3-Lys20, 20 mM [U-2H] sodium acetate, 0.09 mM DSS | 90% H2O/10% D2O | 20 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 2 | 2D 1H-1H COSY | 0.23 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: beta3-Leu13, beta3-Asn17, beta3-Lys20, 20 mM [U-2H] sodium acetate, 0.09 mM DSS | 90% H2O/10% D2O | 20 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 3 | 2D DQF-COSY | 0.23 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: beta3-Leu13, beta3-Asn17, beta3-Lys20, 20 mM [U-2H] sodium acetate, 0.09 mM DSS | 90% H2O/10% D2O | 20 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |
| 4 | 2D 1H-1H NOESY | 0.23 mM Heterogeneous-backbone analogue of plectasin variant NZ2114: beta3-Leu13, beta3-Asn17, beta3-Lys20, 20 mM [U-2H] sodium acetate, 0.09 mM DSS | 90% H2O/10% D2O | 20 mM | 3.8 | 1 atm | 298 | Bruker AVANCE III 700 |